# Chidamide in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (R/R PTCL)

> clinical trial · VERIFIED · 2026-07-07

Status: RECRUITING · Sponsor: Great Novel Therapeutics Biotech & Medicals Corporation · Condition: Relapsed or Refractory Peripheral T-cell Lymphoma

- Company: Great Novel Therapeutics Biotech & Medicals Corporation
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT05833724

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.